Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Small-Cap · Federated Hermes

Federated Hermes Kaufmann Small Cap Fund Class R6 Shares (FKALX)

Ticker FKALX · · Holdings as of Jul 31, 2026

Expense ratio
0.89%$89/yr per $10k
5-yr return
+5.2%annualized
1-yr return
+9.4%as of Dec 2024
Net assets
$2.8Ball share classes
Holdings
149

Bottom line

Is FKALX a good fund? The bottom line

FKALX is the Class R6 share class of Federated Hermes Kaufmann Small Cap Fund, an actively managed small-cap mutual fund from Federated Hermes.

Annual fees run 0.89% — about $89 a year on every $10,000 invested, cheaper than 63% of small-cap funds we track.

It returned +9.4% over one year, +5.2% a year over five years, +11.1% a year over ten (as of Dec 31, 2024, per its prospectus).

With $2.8 billion in net assets and 149 holdings, its largest position is Comfort Systems USA Inc (4.2%) and the top 10 make up 27% of the portfolio.

What stands out

  • No front-end sales load

Updated Nov 19, 2026

What FKALX invests in

The Funds investment objective is to provide capital appreciation.

The Fund pursues its investment objective by investing primarily in the common stocks of small companies that are traded on national security exchanges, the NASDAQ stock market and on the over-the-counter market. Small companies will be defined as companies with market capitalizations that are between the lowest and highest market capitalizations, as measured on a rolling basis over the most recent 36-month period, in either the Russell 2000 Index (which had a rolling 36-month market capitalization range of $1.2 million to $56.5 billion as of October 31, 2025), the S&P Small Cap 600 Index (which had a rolling 36-month market capitalization range of $62.1 million to $29.1 billion as of October 31, 2025), or the MSCI USA Small Cap Index (which had a rolling 36-month market capitalization range of $8.5 million to $40.3 billion as of October 31, 2025). The Fund will normally invest at…

From the fund's prospectus (filed Dec 29, 2025).

FKALX performance

Average annual total returns
1 yr5 yr10 yr
FKALX+9.4%+5.2%+11.1%
Small-Cap median+7.6%+7.0%+9.2%

Source: Fund prospectus, as of Dec 31, 2024

Full FKALX performance history →

What FKALX costs

On a $10,000 investment, FKALX's 0.89% expense ratio costs about $89 a year. The prospectus estimates $1,143 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.

See the full FKALX fee table →

FKALX top 10 holdings

#Holding% of fund
1Comfort Systems USA Inc FIX4.19%
2Argenx SE ARGX3.53%
3Guardant Health Inc GH3.34%
4Ati Inc ATI3.01%
5Forte Biosciences Inc2.24%
6Viking Holdings Ltd VIK2.23%
7Camtek Ltd/Israel CAMT2.14%
8Rhythm Pharmaceuticals Inc RYTM2.13%
9Ul Solutions Inc ULS2.12%
10Sitime Corp SITM2.09%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 27% of the fund. See all top 25 holdings and asset mix →

Alternatives to FKALX

More funds like FKALX →

FKALX FAQ

What is the expense ratio of FKALX?
FKALX's expense ratio is 0.89%, which works out to about $89 a year for every $10,000 invested. The prospectus estimates total costs of $1,143 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is FKALX a good investment?
It depends on your goals, but the data points to: no front-end sales load. This is general information, not personalized advice.
What does FKALX hold?
FKALX's largest holdings are Comfort Systems USA Inc (4.2%), Argenx SE (3.5%), Guardant Health Inc (3.3%), Ati Inc (3.0%), Forte Biosciences Inc (2.2%). It holds 149 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is FKALX's 5-year return?
FKALX returned +5.2% a year over the five years ending Dec 31, 2024, and +11.1% a year over ten years. Past performance does not guarantee future results.
Does FKALX have a sales load?
No. FKALX has no front-end sales charge.
Who manages FKALX?
FKALX is offered by Federated Hermes through Federated Hermes Equity Funds.